Na-K/2Cl transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Prestel, R ^a   Storck, M ^b   Pooth, R ^b   Steinbach, G ^b   Hammer, C ^a   Abendroth, D ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Donor conditioning; Ex vivo hemoperfusion; Kidney transplantation; Piretanide

Indexed keywords

CREATININE; DIURETIC AGENT; ELECTROLYTE; EURO COLLINS SOLUTION; PIRETANIDE; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHLORIDE TRANSPORT; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; GLUCONEOGENESIS; HEMATOCRIT; HENLE LOOP; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY METABOLISM; KIDNEY PERFUSION; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; KIDNEY VASCULAR RESISTANCE; MICTURITION; NONHUMAN; OXYGEN CONSUMPTION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SODIUM TRANSPORT; SWINE;

EID: 0029958480     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01670.x     Document Type: Article

References (16)

1. Abendroth D, Pooth R, Schneeberger H, Land W (1993) Effects of piretanide on early graft function in kidney transplantation - a pilot study. Transplant Proc 25: 2626-2627
2. Booster M, Yin M, Kurvers HAJM, et al (1995) Inhibition of CD18-dependent leukocyte adherence by mAb 6.5 E does not prevent ischemia-reperfusion injury as seen in grafted kidneys. Transplant Int 8: 126-132
3. Clissold SP, Brogden RN (1985) Piretanide - a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drug 29: 489-530
4. Göttl KH, Roesch A, Klinke R (1985) Quantitative evaluation of ototoxic side effects'of furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat - a new approach to the problem of ototoxicity. Naunyn Schmiedeberg's Arch Pharmacol 331: 275-282
5. Hammer C (1994) Nature's obstacles to xenotransplantation. Transplant Rev 8: 174-184
6. Kallerhoff M, Blech M, Kehrer G, et al (1987) Kidney function parameters after ischemic stress under Euro-collins or under HTK protection according to Bretschneider. Urologe 26: 96-103
7. Kaplan MP, Toledo-Pereya LH, Pietroski R, et al (1986) Transplant Proc 18: 504-505
8. Kirsten R, Alexandridis T, Heintz B, et al (1987) Elsevier 365-368
9. Klaus E, Alpermann MG, Caspritz G, Linz W, Scholkens B (1983) Vascular effects of piretanide. Studies on extrarenal action in several animal models. Arzneim Forsch 33: 1273-1276
10. Lawrence JR, Ansari AF, Elliot HL, et al (1978) Kinetic and dynamic comparison of piretanide and furosemide. Clin Pharmacol Ther 23: 558-565
11. Marone C, Reubi FC, Lahn W (1984) Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency. Eur J Clin Pharmacol 26: 413-418
12. Rocher LL, Landers C, Dafoe DC, et al (1987) The importance of prolonged post-transplant dialysis requirement in cyclosporine-treated renal allograft recipients. Clin Transplant 1: 29-36
13. Ross BD, Espinal J, Sliva P (1986) Glucose metabolism in renal tubular function. Kidney Int 29: 54-67
14. Schneeberger H, Schleibner S, Schilling M, et al (1990) Prevention of acute renal failure after kidney transplantation by treatment with rh-SOD: interim analysis of a double-blind placebo controlled trial. Trnasplant Proc 22: 2224-2225
15. Storck M, Sirsjö A, Abendroth D, Hammer C (1995) Laser perfusion imaging (LPI) - a new method of monitoring microcirculation in postischemic organ reperfusion, (submitted)
16. Storck M, Schilling M, Steinbach G, Abendroth D Influence of systemic cyclooxygenase inhibition with single dose aspisol (ASA) on kinetics of arachidonic acid metabolism in the venous effluate of transplanted kidney grafts in humans. Transplant Proc (in press)